University of Chicago

What you'll study

The programme combines focused coursework, core laboratory rotations and an independent research dissertation. Early-stage students undertake foundational courses in molecular pharmacology, cellular signalling, toxicological principles, pharmacokinetics and pharmacodynamics, and experimental design and statistics. Coursework emphasises mechanistic understanding of receptor function, signal transduction, drug metabolism, toxicant-induced injury, and systems-level responses.

Students typically complete a series of laboratory rotations in different faculty laboratories to identify a dissertation mentor. After selecting a lab, the curriculum shifts to advanced, specialised coursework relevant to the chosen project, participation in journal clubs and regular research seminars. Training includes experimental techniques such as in vitro pharmacology, animal models, tissue imaging, mass spectrometry, omics approaches, CRISPR and other genetic tools, and computational analysis where applicable.

Assessment commonly involves passing a qualifying examination (written and/or oral) that demonstrates readiness to pursue dissertation research, formation of a thesis committee, and regular committee meetings to review progress. The doctorate culminates in an original research dissertation and public defence.

Entry requirements

Competitive applicants normally hold a bachelor’s degree in biology, chemistry, biomedical sciences, pharmacology or a closely related discipline; many applicants also present a master’s degree or substantial research experience. Successful candidates demonstrate strong academic performance in core science subjects, hands-on laboratory experience, and clear research interests.

Application materials required typically include a personal statement describing research interests and career goals, a curriculum vitae, academic transcripts, and three letters of recommendation from supervisors or faculty who can evaluate research potential. International applicants must meet the university’s English language proficiency requirements. The programme evaluates candidates holistically on preparation, research potential and fit with faculty expertise.

Career prospects

Graduates pursue a range of careers across academia, biotechnology and pharmaceutical companies, regulatory agencies, clinical translational units and scientific consulting. Common roles include tenure-track faculty, principal scientist in drug discovery or development, toxicologist in industry or government, translational research scientist, and positions in drug safety, pharmacovigilance and regulatory affairs.

Alumni also move into interdisciplinary and applied areas such as systems pharmacology, precision medicine, biomarker development, and computational drug discovery. The training emphasises transferable skills — experimental design, data analysis, scientific communication and project management — that are valuable in both research and industry leadership roles.

Why study at University of Chicago

The University of Chicago offers an intensive, research-centric environment with close mentorship from faculty working at the forefront of basic and translational pharmacology and toxicology. The programme benefits from strong interdisciplinary connections across biological sciences, medicine and engineering, enabling collaborations that span molecular mechanisms to in vivo models and clinical translation.

Students have access to modern core facilities and instrumentation, and to a regional ecosystem of biotech and national laboratories that supports translational projects and industry engagement. The training culture emphasises rigorous experimental design, critical thinking and effective communication, preparing graduates for leadership in research, industry and policy.